Nebenwirkungen · Kyntheum
Kyntheum 210 mg solution for injection in pre-filled syringe · Abschnitt 4.8 · PDF-Seite 5
HOS-133136 · Präparat HOS-097380
Adverse reactions from clinical trials and post-marketing experience (Table 1) are listed by MedDRA system organ class (SOC). Within each SOC, the adverse reactions are ranked by frequency, with the most frequent reactions first. In addition, the corresponding frequency category for each adverse reaction is based on the following convention: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), very rare (<1/10,000) and not known (cannot be estimated from the available data). Within each frequency grouping adverse reactions are presented in order of decreasing seriousness.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-03-13T02:00:00Z · SHA-256 f53cc22ffacce56cbd352c116aa9698330f0807f4955b30e41cde14bacca58a0 · Passage 9b86d0f4bddaeb52596e3b900b16b8a8b4b2465a2fbc58c408b3a1d2db1f40b8 · Zeichen 219–852 im Abschnitt